These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 15253854)

  • 1. Attitudes about complementary and alternative medicine did not predict outcome in a homeopathic proving trial.
    Brien S
    J Altern Complement Med; 2004 Jun; 10(3):503-5. PubMed ID: 15253854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultramolecular homeopathy has no observable clinical effects. A randomized, double-blind, placebo-controlled proving trial of Belladonna 30C.
    Brien S; Lewith G; Bryant T
    Br J Clin Pharmacol; 2003 Nov; 56(5):562-8. PubMed ID: 14651731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized double-blind placebo-controlled trial of homoeopathic 'proving' for Belladonna C30.
    Goodyear K; Lewith G; Low JL
    J R Soc Med; 1998 Nov; 91(11):579-82. PubMed ID: 10325874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homeopathic proving symptoms: result of a local, non-local, or placebo process? A blinded, placebo-controlled pilot study.
    Walach H; Sherr J; Schneider R; Shabi R; Bond A; Rieberer G
    Homeopathy; 2004 Oct; 93(4):179-85. PubMed ID: 15532695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Entanglement, knowledge, and their possible effects on the outcomes of blinded trials of homeopathic provings.
    Milgrom LR
    J Altern Complement Med; 2006 Apr; 12(3):271-9. PubMed ID: 16646726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How do homeopaths make decisions? An exploratory study of inter-rater reliability and intuition in the decision making process.
    Brien S; Prescott P; Owen D; Lewith G
    Homeopathy; 2004 Jul; 93(3):125-31. PubMed ID: 15287431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients' preferences about participation in clinical trials studying complementary and alternative medicine.
    Prasad K; Wahner-Roedler D; Cha S; Sood A
    Altern Ther Health Med; 2011; 17(6):36-42. PubMed ID: 22314718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presentiment or entanglement? An alternative explanation for apparent entanglement in provings.
    Lewith GT; Brien S; Hyland ME
    Homeopathy; 2005 Apr; 94(2):92-5. PubMed ID: 15892489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomised, controlled, triple-blind trial of the efficacy of homeopathic treatment for chronic fatigue syndrome.
    Weatherley-Jones E; Nicholl JP; Thomas KJ; Parry GJ; McKendrick MW; Green ST; Stanley PJ; Lynch SP
    J Psychosom Res; 2004 Feb; 56(2):189-97. PubMed ID: 15016577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homeopathic pathogenetic trials produce more specific than non-specific symptoms: results from two double-blind placebo controlled trials.
    Walach H; Möllinger H; Sherr J; Schneider R
    J Psychopharmacol; 2008 Jul; 22(5):543-52. PubMed ID: 18701641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind, randomized, homeopathic pathogenetic trial with healthy persons: comparing two high potencies.
    Möllinger H; Schneider R; Löffel M; Walach H
    Forsch Komplementarmed Klass Naturheilkd; 2004 Oct; 11(5):274-80. PubMed ID: 15572868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing homeopathic proving using questionnaire methodology: consideration and implications for future studies.
    Brien S; Lewith G
    Forsch Komplementarmed Klass Naturheilkd; 2005 Jun; 12(3):152-8. PubMed ID: 15985780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are the therapeutic effects of homeopathy attributed to the consultation, the homeopathic remedy, or both? A protocol for a future exploratory feasibility trial in patients with rheumatoid arthritis.
    Brien S; Lachance L; Lewith GT
    J Altern Complement Med; 2004 Jun; 10(3):499-502. PubMed ID: 15253853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postmodern values, attitudes and the use of complementary medicine.
    O'Callaghan FV; Jordan N
    Complement Ther Med; 2003 Mar; 11(1):28-32. PubMed ID: 12667972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The N-of-1 Clinical Trial: A Timely Research Opportunity in Homeopathy.
    Ulbrich-Zürni S; Teut M; Roll S; Mathie RT
    Homeopathy; 2018 Feb; 107(1):10-18. PubMed ID: 29528474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individual differences in response to randomly assigned active individualized homeopathic and placebo treatment in fibromyalgia: implications of a double-blinded optional crossover design.
    Bell IR; Lewis DA; Brooks AJ; Schwartz GE; Lewis SE; Caspi O; Cunningham V; Baldwin CM
    J Altern Complement Med; 2004 Apr; 10(2):269-83. PubMed ID: 15165408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A homoeopathic proving of Galphimia glauca.
    Teut M; Dahler J; Schnegg C;
    Forsch Komplementmed; 2008 Aug; 15(4):211-7. PubMed ID: 18787330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and correlates of selected alternative and complementary medicine in adult renal transplant patients.
    Hess S; De Geest S; Halter K; Dickenmann M; Denhaerynck K
    Clin Transplant; 2009; 23(1):56-62. PubMed ID: 18786136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protocol for a phase 1 homeopathic drug proving trial.
    Teut M; Hirschberg U; Luedtke R; Schnegg C; Dahler J; Albrecht H; Witt CM
    Trials; 2010 Jul; 11():80. PubMed ID: 20649979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring attitudes toward, and knowledge of, homeopathy and CAM through focus groups.
    Furnham A
    Complement Ther Nurs Midwifery; 2002 Feb; 8(1):42-7. PubMed ID: 11898909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.